Possible mechanism of intravenous immunoglobulin treatment on anti-GM1 antibody-mediated neuropathies

Journal of the Neurological Sciences

Volumn 139, Issue 1, 1996, Pages 160-162

  Yuki, Nobuhiro ^a,b,d   Miyagi, Fuminori ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Saitoh Memorial Hospital   (Japan)

^c TEIJIN LTD   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti GM1 antibody; Cholera toxin; Idiotype; Intravenous immunoglobulin

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN IDIOTYPE; SIALIDASE; SULFONATED IMMUNOGLOBULIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; NEUROPATHY; PRIORITY JOURNAL;

EID: 0030200642     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00053-6     Document Type: Article

References (20)

1. Arasaki, K., Kusunoki, S., Kudo, N. and Kanazawa, I. (1993) Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 16, 587-593.
2. Azulay, J.-P., Blin, O., Pouget, J., Boucraut, J., Bille-Turc, F., Carles, G. and Serratrice, G. (1994) Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology 44, 429-432.
3. Chapman, P.B. and Houghton, A.N. (1991) Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody. J. Clin. Invest. 88, 186-192.
4. Dyck, P.J., Litchy, W.J., Kratz, K.M., Suarez, G.A., Low, P.A., Pineda, A.A., Windebank, A.J., Karnes, J.L. and O'Brien, P.C. (1994) A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann. Neurol. 36, 838-845.
5. Hastings, A., Morrison, S.L., Kanda, S., Saxton, R.E. and Irie, R.F. (1992) Production and characterization of a murine/human chimeric anti-idiotype antibody that mimics ganglioside. Cancer Res. 52, 1681-1686.
6. Heiman-Patterson, T., Krupa, T., Thompson, P., Nobile-Orazio, E., Tahmoush, A.J. and Shy, M.E. (1993) Anti-GM1/GD1b M-proteins damage human spinal cord neurons co-cultured with muscle. J. Neurol. Sci. 120, 38-45.
7. Lundkvist, I., Van Doorn, P.A., Vermeulen, M. and Brand, A. (1993) Spontaneous recovery from the Guillain-Barré syndrome is associated with anti-idiotypic antibodies recognizing a cross-reactive idiotype on anti-neuroblastoma cell line antibodies. Clin. Immunol. Immunopathol. 67, 192-198.
8. Oldenburg, K.R., Loganathan, D., Goldstein, I.L., Schultz, P.G. and Gallop M.A. (1992) Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. USA. 89, 5393-5397.
9. Pestronk, A., Cornblath, D.R., Ilyas, A.A., Baba, H., Quarles, R.H., Griffin, J.W., Alderson, K. and Adams, R.N. (1988) A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann. Neurol. 24, 73-78.
10. Roberts, M., Willison, H.J., Vincent, A. and Newsom-Davis, J. (1995) Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann. Neurol. 38, 111-118.
11. Santoro, M., Uncini, A., Corbo, M., Staugaitis, S.M., Thomas, F.P., Hays, A.P. and Latov, N. (1992) Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann. Neurol. 31, 385-390.
12. Scott, J.K., Loganathan, D., Easley, R.B. and Gong X. (1992) A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc. Natl. Acad. Sci. USA 89, 5398-5402.
13. + currents in isolated myelinated nerve fibers. Ann. Neurol. 37, 436-442.
14. Thornton, C.A. and Griggs, R.C. (1994) Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann. Neurol. 35, 260-268.
15. Uncini, A., Santoro, M., Corbo, M., Lugaresi, A. and Latov, N. (1993) Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 16, 610-615.
16. Van der Meché, F.G.A., Schmitz, P.I.M. and the Dutch Guillain-Barré Study Group. (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N. Engl. J. Med. 326, 1123-1129.
17. Van Doorn, P.A., Brand, A., Strengers, P.F.W., Meulstee, J. and Vermeulen, M. (1990a) High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology 40, 209-212.
18. Van Doorn, P.A., Rossi, F., Brand, A., Van Lint, M., Vermeulen, M. and Kazatchkine M.D. (1990b) On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 29, 57-64.
19. Van Schaik, I.N., Vermeulen, M., Van Doorn, P.A. and Brand, A. (1994) Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg). J. Neuroimmunol. 54, 109-115.
20. Yuki, N., Yoshino, H., Sato, S. and Miyatake, T. (1990) Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40, 1900-1902.